London-based AI-driven antibody drug discovery specialist LabGenius Ltd has closed a £35m Series B financing round.
ADVERTISEMENT
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
London-based AI-driven antibody drug discovery specialist LabGenius Ltd has closed a £35m Series B financing round.

